-
The Relation Of Oxidative Stress Biomarkers With Proinflammatory Cytokines In Gestational Diabetes
Sema Genc, Zeynep Kusku-Kiraz, Elmire Dervisoglu, Nida Oztop, Nevin Dinccag, Figen Gurdol
Research Article: Clinical Investigation
-
The Relation Of Oxidative Stress Biomarkers With Proinflammatory Cytokines In Gestational Diabetes
Sema Genc, Zeynep Kusku-Kiraz, Elmire Dervisoglu, Nida Oztop, Nevin Dinccag, Figen Gurdol
Research Article: Clinical Investigation
-
The Relation Of Oxidative Stress Biomarkers With Proinflammatory Cytokines In Gestational Diabetes
Sema Genc, Zeynep Kusku-Kiraz, Elmire Dervisoglu, Nida Oztop, Nevin Dinccag, Figen Gurdol
Research Article: Clinical Investigation
-
The Relation Of Oxidative Stress Biomarkers With Proinflammatory Cytokines In Gestational Diabetes
Sema Genc, Zeynep Kusku-Kiraz, Elmire Dervisoglu, Nida Oztop, Nevin Dinccag, Figen Gurdol
Research Article: Clinical Investigation
-
The Relation Of Oxidative Stress Biomarkers With Proinflammatory Cytokines In Gestational Diabetes
Sema Genc, Zeynep Kusku-Kiraz, Elmire Dervisoglu, Nida Oztop, Nevin Dinccag, Figen Gurdol
Research Article: Clinical Investigation
-
The Relation Of Oxidative Stress Biomarkers With Proinflammatory Cytokines In Gestational Diabetes
Sema Genc, Zeynep Kusku-Kiraz, Elmire Dervisoglu, Nida Oztop, Nevin Dinccag, Figen Gurdol
Research Article: Clinical Investigation
-
The Relation Of Oxidative Stress Biomarkers With Proinflammatory Cytokines In Gestational Diabetes
Sema Genc, Zeynep Kusku-Kiraz, Elmire Dervisoglu, Nida Oztop, Nevin Dinccag, Figen Gurdol
Research Article: Clinical Investigation
-
The Relation Of Oxidative Stress Biomarkers With Proinflammatory Cytokines In Gestational Diabetes
Sema Genc, Zeynep Kusku-Kiraz, Elmire Dervisoglu, Nida Oztop, Nevin Dinccag, Figen Gurdol
Research Article: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
New treatment for Cushins disease given European Medicines Agency recommendation
News and Views: Clinical Investigation
-
New treatment for Cushins disease given European Medicines Agency recommendation
News and Views: Clinical Investigation
-
New treatment for Cushins disease given European Medicines Agency recommendation
News and Views: Clinical Investigation
-
New treatment for Cushins disease given European Medicines Agency recommendation
News and Views: Clinical Investigation
-
New treatment for Cushins disease given European Medicines Agency recommendation
News and Views: Clinical Investigation
-
New treatment for Cushins disease given European Medicines Agency recommendation
News and Views: Clinical Investigation
-
New treatment for Cushins disease given European Medicines Agency recommendation
News and Views: Clinical Investigation
-
New treatment for Cushins disease given European Medicines Agency recommendation
News and Views: Clinical Investigation